文献
J-GLOBAL ID:202102289005052323
整理番号:21A0290657
再発性または難治性急性白血病の成人患者における二重PI3-キナーゼ/mTOR阻害剤BEZ235の第I相試験【JST・京大機械翻訳】
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia
著者 (14件):
Lang Fabian
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Wunderle Lydia
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Badura Susanne
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Schleyer Eberhard
(Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany)
,
Brueggemann Monika
(Department of Hematology, UKSH, Campus Kiel, Kiel, Germany)
,
Serve Hubert
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Serve Hubert
(DKFZ Heidelberg, Heidelberg, Germany)
,
Schnittger Susanne
(Muenchner Leukaemie Labor, Munich, Germany)
,
Gokbuget Nicola
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Pfeifer Heike
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Wagner Sebastian
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Ashelford Kevin
(School of Medicine, Cardiff University, Cardiff, UK)
,
Bug Gesine
(Department of Medicine, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany)
,
Ottmann Oliver G.
(School of Medicine, Cardiff University, Cardiff, UK)
資料名:
BMC Pharmacology and Toxicology (Web)
(BMC Pharmacology and Toxicology (Web))
巻:
21
号:
1
ページ:
1-14
発行年:
2020年
JST資料番号:
U7310A
ISSN:
2050-6511
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)